AusPAR: Rifaximin

Australian Public Assessment Report

AusPAR

AusPAR: Rifaximin [PDF, 752.3 KB]

AusPAR: Rifaximin [Word, 998.43 KB]

Attachment: Product Information: Rifaximin [PDF, 178.8 KB]

Attachment: Product Information: Rifaximin [Word, 153.5 KB]

Attachment: Extract from Clinical Evaluation Report: Rifaximin [PDF, 2.19 MB]

Attachment: Extract from Clinical Evaluation Report: Rifaximin [Word, 4.45 MB]

Device/Product Name

Xifaxan

Active ingredients

Rifaximin

AusPAR Date

13 October 2015

Published

1 December 2015

Submission Number

PM-2014-00379-1-2

Submission Type

Extension of indications

Decision

Approved